A course designed to equip individuals implementing GCLP within laboratories handling samples from clinical trials
More informationJoin the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationThanks to EUSurvey, the European Commission's tool, all Medical Devices Notified Bodies (n=54) received on September 28th, 2020, an invitation to the survey 'Notified Body Experience with Remote Auditing'. The survey was closed on October 29th. At that time, 37 Notified Bodies responded to the survey.
The way clinical trials are conducted in the EU will undergo a major change when the Clinical Trial Regulation (Regulation (EU) No 536/2014) comes into application. The Regulation harmonises the assessment and supervision processes for clinical trials throughout the EU, via a Clinical Trials Information System (CTIS). CTIS will contain the centralised EU portal and database for clinical trials foreseen by the Regulation and will be used by clinical trial sponsors as a single entry point in the EU to obtain approval for clinical trials based on applications and for monitoring clinical trials during their life cycle, including the submission of summary of results.
EMA is organising an webinar for industry on its Organisations Management Service (OMS) and Referentials Management Service (RMS) activities, on 03/02/2021 and 04/02/2021. While it is a general webinar, it will provide relevant information to sponsor organisations that will be using CTIS in future.
The transition period for the United Kingdom's departure from the EU is over and new guidance on a matter of topics has been released by the MHRA.
The strategy details how the European medicines regulatory network can continue to enable the supply of safe and effective medicines that meet patients’ needs in the face of challenges posed by ever-accelerating developments in science, medicine, digital technologies, globalisation as well as emerging health threats, such as the COVID-19 pandemic.
The new 'Guidance on interpretation and implementation' of the ECA Foundation and the PQG of the CQI
A blog post by Emanuela Krasteva and Peter Brown, 21 December 2020
EMA and the Heads of Medicines Agencies (HMA) have published their joint strategy for the next five years, following its recent adoption by the HMA and EMA Management Board.
EMA has published a Question & Answer on what type of studies are needed to approve a COVID-19 vaccine.
CTIS Highlights Newsletter